❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive ❭

Digital Public Defence Apr. 26, 2021 12:15 Maxi-Lu Böschen

Maxi-Lu Böschen
Maxi-Lu Böschen

MSc Maxi-Lu Böschen from the Experimental Immunotherapy Group headed by Johanna Olweus will be defending her thesis Towards new T cell receptor-based cancer immunotherapy for the degree of PhD (Philosophiae Doctor).

Time and place: Apr. 26, 2021 12:15 PM, Zoom
 

Links:

Read complete announcement from UiO home page

Maxi-Lu Böschen

The Experimental Immunotherapy Group, headed by Johanna Olweus

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Imaging facilities
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Rusten TE (2025)
Autophagy regulation by signaling
Curr Opin Cell Biol, 97, 102595 (in press)
DOI 10.1016/j.ceb.2025.102595, PubMed 41086756

Høyvik AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, Peng Q, Wangen-Riise R, Wiig E, Ma LW, Revheim ME, Juzeniene A (2025)
Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts
J Nucl Med (in press)
DOI 10.2967/jnumed.125.270444, PubMed 41043994

Pharo H, Vedeld HM, Wahlqvist R, Lind GE (2025)
Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30
Eur Urol (in press)
DOI 10.1016/j.eururo.2025.07.028, PubMed 40998632

More selected publications

Most recent publications

Emaldi M, Rey-Iborra E, Alamillo-Maeso P, Pulido R, Nunes-Xavier CE (2026)
Analysis of the Functional Impact of Glycosylation on Immune Checkpoint Proteins
Methods Mol Biol, 2959, 55-72
DOI 10.1007/978-1-0716-4734-9_4, PubMed 41028258

Pharo H, Brandt-Winge S, Thorkildsen EM, Vedeld HM, Lind GE (2026)
DNA Methylation Analyses of Tissue Samples and Cell-Free DNA by Droplet Digital PCR
Methods Mol Biol, 2969, 179-193
DOI 10.1007/978-1-0716-4767-7_12, PubMed 41073866

Rey-Iborra E, Emaldi M, Madariaga M, Pulido R, Nunes-Xavier CE (2026)
3D Spheroids to Study the Impact of Immune Checkpoint Proteins in Solid Tumors
Methods Mol Biol, 2959, 141-156
DOI 10.1007/978-1-0716-4734-9_10, PubMed 41028264

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)